These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 33476459)
1. Protocol driven periprocedural anticoagulation for left atrial ablation. Bradley CJ; Williamson BD; George J; Haines DE J Cardiovasc Electrophysiol; 2021 Mar; 32(3):639-646. PubMed ID: 33476459 [TBL] [Abstract][Full Text] [Related]
2. Periprocedural management of anticoagulation for atrial fibrillation catheter ablation in direct oral anticoagulant-treated patients. Martin AC; Lessire S; Leblanc I; Dincq AS; Philip I; Gouin-Thibault I; Godier A Clin Cardiol; 2018 May; 41(5):646-651. PubMed ID: 29532536 [TBL] [Abstract][Full Text] [Related]
3. Higher initial weight-based heparin dosing is required with direct oral anticoagulants during catheter ablation for atrial fibrillation. Payne JE; Koerber SM; Bickel T; Ghadban R; Flaker G; Gautam S J Interv Card Electrophysiol; 2020 Aug; 58(2):185-191. PubMed ID: 31230179 [TBL] [Abstract][Full Text] [Related]
4. Comprehensive Intraprocedural Unfractionated Heparin Protocol During Catheter Ablation of Atrial Fibrillation in the Presence of Direct Oral Anticoagulants and Wide Spectrum of Body Mass Index. Safani M; Tobias S; Shandling AH; Redmond K; Lee MY J Cardiovasc Pharmacol Ther; 2021 Jul; 26(4):349-358. PubMed ID: 33749350 [TBL] [Abstract][Full Text] [Related]
5. Impact of international normalized ratio and activated clotting time on unfractionated heparin dosing during ablation of atrial fibrillation. Hamam I; Daoud EG; Zhang J; Kalbfleisch SJ; Augostini R; Winner M; Tsai S; Rhodes TE; Houmsse M; Liu Z; Love CJ; Tyler J; Sachdev M; Weiss R; Hummel JD Circ Arrhythm Electrophysiol; 2013 Jun; 6(3):491-6. PubMed ID: 23685538 [TBL] [Abstract][Full Text] [Related]
6. Periprocedural anticoagulation in the uninterrupted edoxaban vs. vitamin K antagonists for ablation of atrial fibrillation (ELIMINATE-AF) trial. Hohnloser SH; Camm AJ; Cappato R; Diener HC; Heidbüchel H; Mont L; Morillo CA; Lanz HJ; Rauer H; Reimitz PE; Smolnik R; Kautzner J Europace; 2021 Jan; 23(1):65-72. PubMed ID: 33249467 [TBL] [Abstract][Full Text] [Related]
7. Differences in activated clotting time and total unfractionated heparin dose during pulmonary vein isolation in patients on different anticoagulation therapy. Zeljkovic I; Brusich S; Scherr D; Velagic V; Traykov V; Pernat A; Anic A; Szavits Nossan J; Jan M; Bakotic Z; Pezo Nikolic B; Radeljic V; Bojko A; Benko I; Manola S; Pavlovic N Clin Cardiol; 2021 Aug; 44(8):1177-1182. PubMed ID: 34196416 [TBL] [Abstract][Full Text] [Related]
9. Effect of pre-procedural interrupted apixaban on heparin anticoagulation during catheter ablation for atrial fibrillation: a prospective observational study. Bin Abdulhak AA; Kennedy KF; Gupta S; Giocondo M; Ramza B; Wimmer AP J Interv Card Electrophysiol; 2015 Nov; 44(2):91-6. PubMed ID: 26292959 [TBL] [Abstract][Full Text] [Related]
10. Higher Maximum Doses and Infusion Rates Compared with Standard Unfractionated Heparin Therapy Are Associated with Adequate Anticoagulation without Increased Bleeding in Both Obese and Nonobese Patients with Cardiovascular Indications. Floroff CK; Palm NM; Steinberg DH; Powers ER; Wiggins BS Pharmacotherapy; 2017 Apr; 37(4):393-400. PubMed ID: 28107569 [TBL] [Abstract][Full Text] [Related]
11. Safety of novel oral anticoagulants compared with uninterrupted warfarin for catheter ablation of atrial fibrillation. Armbruster HL; Lindsley JP; Moranville MP; Habibi M; Khurram IM; Spragg DD; Berger RD; Calkins H; Marine JE Ann Pharmacother; 2015 Mar; 49(3):278-84. PubMed ID: 25515868 [TBL] [Abstract][Full Text] [Related]
12. Heparin dosing in uninterrupted anticoagulation with dabigatran vs. warfarin in atrial fibrillation ablation: RE-CIRCUIT study. Calkins H; Willems S; Verma A; Schilling R; Hohnloser SH; Okumura K; Nordaby M; Kleine E; Bis B; Gerstenfeld EP Europace; 2019 Jun; 21(6):879-885. PubMed ID: 30982849 [TBL] [Abstract][Full Text] [Related]
13. Running after Activated Clotting Time Values in Patients Receiving Direct Oral Anticoagulants: A Potentially Dangerous Race. Results from a Prospective Study in Atrial Fibrillation Catheter Ablation Procedures. Benali K; Verain J; Hammache N; Guenancia C; Hooks D; Magnin-Poull I; Toussaint-Hacquard M; de Chillou C; Sellal JM J Clin Med; 2021 Sep; 10(18):. PubMed ID: 34575348 [TBL] [Abstract][Full Text] [Related]
14. [Impact of different anticoagulation therapies on heparin dosage applied to atrial fibrillation patients undergoing atrial fibrillation catheter ablation]. Yang L; Gao LJ; Yin XM; Guo BL Zhonghua Xin Xue Guan Bing Za Zhi; 2019 Aug; 47(8):602-607. PubMed ID: 31434430 [No Abstract] [Full Text] [Related]
15. Does periprocedural anticoagulation management of atrial fibrillation affect the prevalence of silent thromboembolic lesion detected by diffusion cerebral magnetic resonance imaging in patients undergoing radiofrequency atrial fibrillation ablation with open irrigated catheters? Results from a prospective multicenter study. Di Biase L; Gaita F; Toso E; Santangeli P; Mohanty P; Rutledge N; Yan X; Mohanty S; Trivedi C; Bai R; Price J; Horton R; Gallinghouse GJ; Beheiry S; Zagrodzky J; Canby R; Leclercq JF; Halimi F; Scaglione M; Cesarani F; Faletti R; Sanchez J; Burkhardt JD; Natale A Heart Rhythm; 2014 May; 11(5):791-8. PubMed ID: 24607716 [TBL] [Abstract][Full Text] [Related]
16. Use of a New Standardized Unfractionated Heparin Protocol for Left-Sided Ablation Procedures Improves Time in the Therapeutic ACT Range. Ural KG; Moridzadeh SS; Busch EH; Masri OE; Burton JH; Morin DP J Cardiothorac Vasc Anesth; 2024 Jan; 38(1):67-72. PubMed ID: 38030427 [TBL] [Abstract][Full Text] [Related]
17. A novel protocol for initial heparin administration during catheter ablation for atrial fibrillation in patients taking direct oral anticoagulants. Kishima H; Mine T; Fukuhara E; Ashida K; Ishihara M; Masuyama T Heart Vessels; 2019 May; 34(5):832-841. PubMed ID: 30390125 [TBL] [Abstract][Full Text] [Related]
18. Differences in activated clotting time and initial heparin dosage during atrial fibrillation ablation for patients with edoxaban compared with warfarin. Yamaji H; Murakami T; Hina K; Higashiya S; Kawamura H; Murakami M; Kamikawa S; Hirohata S; Kusachi S J Cardiovasc Electrophysiol; 2018 Jun; 29(6):835-843. PubMed ID: 29533476 [TBL] [Abstract][Full Text] [Related]
19. Activated clotting time on the day of atrial fibrillation ablation for minimally interrupted and uninterrupted direct oral anticoagulation therapy: Sequential changes, differences among direct oral anticoagulants, and ablation safety outcomes. Yamaji H; Murakami T; Hina K; Higashiya S; Kawamura H; Murakami M; Kamikawa S; Hirohata S; Kusachi S J Cardiovasc Electrophysiol; 2019 Dec; 30(12):2823-2833. PubMed ID: 31701593 [TBL] [Abstract][Full Text] [Related]
20. Immediate post-procedure bridging with unfractioned heparin versus low molecular weight heparin in patients undergoing radiofrequency ablation for atrial fibrillation with an interrupted oral anticoagulation strategy. Loughlin G; Romaniega TD; Garcia-Fernandez J; Calvo D; Salgado R; Alonso A; Li X; Arenal A; González-Torrecilla E; Atienza F; Fernández-Avilés F J Interv Card Electrophysiol; 2016 Mar; 45(2):149-58. PubMed ID: 26739484 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]